Linical

2183.T

Tags: JP Healthcare Biotechnology

Linical Co., Ltd. Price (2183.T)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

22,586,436

(0)%

Market Cap of Linical (2183.T)

Market cap:

As of , 2183.T has a market cap of . This makes 2183.T the 2458th most valuable company in the JP by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research se... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $323-463
Market Cap 7.61B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Kazuhiro Hatano
IPO Date: October, 27, 2008
Country: JP
Currency: JPY
Headquaters: No Data
Employees: 662

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: